Anaptysbio (ANAB) Enterprise Value (2016 - 2025)
Anaptysbio's Enterprise Value history spans 10 years, with the latest figure at -$311.6 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 19.13% year-over-year to -$311.6 million; the TTM value through Dec 2025 reached -$311.6 million, up 19.13%, while the annual FY2025 figure was -$311.6 million, 19.13% up from the prior year.
- Enterprise Value reached -$311.6 million in Q4 2025 per ANAB's latest filing, down from -$249.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$249.0 million in Q3 2025 to a low of -$548.1 million in Q4 2021.
- Average Enterprise Value over 5 years is -$389.0 million, with a median of -$388.1 million recorded in 2023.
- Peak YoY movement for Enterprise Value: tumbled 39.23% in 2021, then skyrocketed 42.12% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$548.1 million in 2021, then rose by 19.5% to -$441.2 million in 2022, then rose by 11.41% to -$390.9 million in 2023, then increased by 1.41% to -$385.4 million in 2024, then increased by 19.13% to -$311.6 million in 2025.
- Per Business Quant, the three most recent readings for ANAB's Enterprise Value are -$311.6 million (Q4 2025), -$249.0 million (Q3 2025), and -$265.7 million (Q2 2025).